Results 161 to 170 of about 178,663 (403)

Comprehensive exploration of unexplained dyspnoea in subjects with normal ejection fraction and low natriuretic peptides

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 879-887, April 2025.
Abstract Background Unexplained exertional dyspnoea without significant elevation of natriuretic peptides is common. One of the causes might be early heart failure with preserved ejection fraction (HFpEF). Aims This study aimed to characterize patients with exertional dyspnoea and normal/near‐to‐normal N‐terminal pro‐brain natriuretic peptide (NT ...
Emmanuelle Berthelot   +8 more
wiley   +1 more source

Vertigo in childhood

open access: yes, 1991
Vertigo occurs less frequently in childhood than in adulthood. If present, however, it can be caused by a variety of peripheral and central vestibular syndromes that pose a diagnostic challenge (Beddoe 1977; Eviatar and Eviatar 1977; Blayney and Colman 1984; Brandt and Buchele 1984; Balkany and Finkel 1986; Britton and Block 1988; Eviatar 1994; Bower ...
openaire   +2 more sources

Clinical Practice Guideline: Benign Paroxysmal Positional Vertigo (Update)

open access: yesOtolaryngology Head & Neck Surgery, 2017
N. Bhattacharyya   +15 more
semanticscholar   +1 more source

Cilostazol in patients with heart failure and preserved ejection fraction—The CLIP‐HFpEF trial

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1437-1446, April 2025.
• Cilostazol is an oral PDE‐3 inhibitor that may have advantageous effects in heart failure with preserved ejection fraction (HFpEF). • Cilostazol significantly improved short‐term heart failure‐related health status scores (KCCQ‐12) and NT‐proBNP levels when compared to placebo.
Norman Aiad   +9 more
wiley   +1 more source

Exploring safety of down‐titrating diuretics in heart failure management

open access: yesEuropean Journal of Heart Failure, EarlyView.
Event probabilities following down‐titration (), up‐titration (), or no dose change (=). One person represents approximately 10% of cases. Abstract Aims Loop diuretics are widely used in heart failure (HF) for symptom relief. Guidelines advise treating patients with the lowest possible dose of loop diuretics to maintain euvolaemia, based on expert ...
Chrit B.G. Geraeds   +5 more
wiley   +1 more source

Cardio‐microcurrent device treatment for heart failure with reduced ejection fraction: Results from the C‐MIC II open‐label randomized controlled trial

open access: yesEuropean Journal of Heart Failure, EarlyView.
Efficacy and Safety of C‐MIC Device in Patients with Heart Failure with Reduced Ejection Fraction. 6MWD, 6‐min walk distance; CI, confidence interval; KCCQ‐OSS, Kansas City Cardiomyopathy Questionnaire overall summary score; LVEF, left ventricular ejection fraction; NYHA, New York Heart Association.
Jesus E. Rame   +24 more
wiley   +1 more source

Home - About - Disclaimer - Privacy